Piet Houwen, Dirk Zimmermann, Hilde Eylenbosch
Biocartis has announced several changes to its management team. The firm has appointed Piet Houwen as its chief operating officer earlier this month. Prior to joining Biocartis, Houwen served as COO at Ablynx. Before Ablynx, he held global roles for Sanofi/Genzyme and Janssen Pharmaceutica (part of Johnson & Johnson family of companies).
Biocartis has also appointed Dirk Zimmermann as its global head pharma collaborations and partnering. Zimmerman will assume the position at the firm in May. Prior to joining Biocartis, Zimmermann held positions at Roche Diagnostics and Qiagen in product development and corporate venturing.
Biocartis has also let go of Hilde Eylenbosch as the firm's chief commercial officer, effective at the end of April. The firm does not have plans to immediately appoint a new CCO, as it will redistribute the tasks to the company's CEO and senior commercial management.